Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KANWAL PS RAGHAV

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1871708198
CMS profile
814983
Location
HOUSTON, TX

General Payments · PY2018–2024

$166,012.75

  • Reported across 159 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$40,465.16

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
SANOFI US SERVICES INC. $14,355.00 2
ABBVIE INC. $12,171.13 7
Eli Lilly and Company $4,522.06 11
Acerta Pharma LLC $3,425.00 1
JAZZ PHARMACEUTICALS INC. $2,730.00 1
Bayer HealthCare Pharmaceuticals Inc. $2,621.25 1
ARRAY BIOPHARMA INC $315.00 1
PFIZER INC. $164.54 3
AstraZeneca UK Limited $135.00 1
Genentech, Inc. $26.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $11,639.45 21
PY2019 $24,864.71 32
PY2020 $25,803.23 27
PY2021 $12,673.75 7
PY2022 $16,313.85 19
PY2023 $34,252.60 24
PY2024 $40,465.16 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $4,950.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1105349092 CMS
ABBVIE INC. $75.02 01/03/2024 Travel and Lodging Undisputed 01/23/2026 1105349097 CMS
ABBVIE INC. $167.91 01/03/2024 Food and Beverage Undisputed 01/23/2026 1105349101 CMS
ABBVIE INC. $25.00 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105349104 CMS
ABBVIE INC. $53.20 05/30/2024 Food and Beverage Undisputed 01/23/2026 1105349109 CMS
ABBVIE INC. $3,900.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1105349113 CMS
ABBVIE INC. $3,000.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1105349117 CMS
ARRAY BIOPHARMA INC $315.00 05/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131342970 CMS
AstraZeneca Pharmaceuticals LP $3,425.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1110549184 CMS
AstraZeneca UK Limited $135.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 1110544533 CMS
Bayer Healthcare Pharmaceuticals Inc. $2,621.25 04/24/2024 Consulting Fee Undisputed 01/23/2026 1086217135 CMS
Eli Lilly and Company $404.48 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135075989 CMS
Eli Lilly and Company $299.00 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135089281 CMS
Eli Lilly and Company $95.22 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135090039 CMS
Eli Lilly and Company $354.25 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135093155 CMS
Eli Lilly and Company $44.10 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135094714 CMS
Eli Lilly and Company $8.68 04/26/2024 Food and Beverage Undisputed 01/23/2026 1135094716 CMS
Eli Lilly and Company $222.11 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135105357 CMS
Eli Lilly and Company $426.86 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135115046 CMS
Eli Lilly and Company $131.67 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135115048 CMS
Eli Lilly and Company $135.69 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1135118765 CMS
Eli Lilly and Company $2,400.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 1135093153 CMS
Genentech, Inc. $26.18 09/06/2024 Food and Beverage Undisputed 01/23/2026 1133044072 CMS
JAZZ PHARMACEUTICALS INC. $2,730.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1150236232 CMS
PFIZER INC. $78.54 01/18/2024 Food and Beverage Undisputed 01/23/2026 1131288904 CMS
PFIZER INC. $25.00 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131469405 CMS
PFIZER INC. $61.00 04/07/2024 Food and Beverage Undisputed 01/23/2026 1131297218 CMS
SANOFI US SERVICES INC. $5,880.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1139877061 CMS
SANOFI US SERVICES INC. $8,475.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 1139877059 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.